The European Patent Office (EPO) has published patent application EP4534073A2, filed by Oak Hill Bio Limited, concerning "Compositions Suitable for Use in Neonates." The patent details specific therapeutic compositions, including those involving peptides and excipients, designed for administration to neonates. The publication lists various International Patent Classification (IPC) codes related to pharmaceutical preparations and their therapeutic uses, such as A61K (Preparations for medical, dental or toilet purposes) and A61P (Specific therapeutic activity of chemical compounds or medicinal preparations).

This patent publication represents a new intellectual property filing and does not impose immediate compliance obligations on regulated entities. However, it signifies potential future developments in neonatal therapeutics. Companies involved in the development or manufacturing of pharmaceuticals for neonates should be aware of this patent as it may impact future product development, licensing, or market exclusivity in the designated European states.